ArticleContact lens & anterior eye : the journal of the British Contact Lens Association2025
Impact of definition of meibomian gland dysfunction on the frequency of MGD in dry eye disease from the DREAM© study.
Article in Contact lens & anterior eye : the journal of the British Contact Lens Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bioactive Properties of Carotenoids in Ocular Diseases: Antioxidant, Anti-Inflammatory, and Neuroprotective Effects.Nutrients · 2026Review
- Systematic Review and Meta-Analysis: Prevalence of Meibomian Gland Dysfunction Among Adults Aged 40 Years and Older.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeMeibomian gland dysfunction (MGD) is a common disease, yet there is no standard clinical definition. This study explored the frequency and characteristics of MGD in dry eye disease (DED) using different clinical definitions.
methodsA secondary analysis of data collected from the DREAM© study participants (n = 535) with moderate-to-severe DED was undertaken. Three common MG clinical features; plugging, secretion quality, and MG atrophy grade, either separately or in combination were used to create MGD definitions. The frequency of MGD, defined by the per eye findings, was reported. Demographic characteristics were compared between those with and without MGD.
resultsThe frequency of MGD in DED varied from 12 % (gland plugging, plus poor secretion quality plus gland atrophy) to 55 % (gland plugging alone) of eyes. Older age was associated with MGD when atrophy-based definitions were used (p < 0.001) but was not associated with MGD definitions using plugging or secretion quality (p > 0.05). After adjustment for age and between-eye correlations, MGD frequency was higher in women for definitions based on lower lid gland atrophy (adjusted p < 0.05). Hispanic or Latino ethnicity was more commonly associated with MGD than other ethnicities (adjusted p < 0.001), for definitions based on plugging and secretion quality.
conclusionThe frequency of MGD in DED varied with MGD definition. The highest frequency occurred where MGD was defined as lower eyelid gland plugging. Gland atrophy increased with age. The variation in disease frequency has implications for clinical diagnosis and determining efficacy assessment in intervention studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.